Arellano, Josefina G.
HRN: 05-28-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/02/2023
03/08/2023
IV
2.25g
Q6
CAP HR (Revised From 4.5g Q6)
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes